{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:29:10Z","timestamp":1786987750693,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08DA049905"],"award-info":[{"award-number":["K08DA049905"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA051684"],"award-info":[{"award-number":["K01DA051684"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP2DA051864"],"award-info":[{"award-number":["DP2DA051864"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01D056654"],"award-info":[{"award-number":["K01D056654"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.drugalcdep.2024.111409","type":"journal-article","created":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T10:00:18Z","timestamp":1722160818000},"page":"111409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015\u20132019"],"prefix":"10.1016","volume":"262","author":[{"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Yamkovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi Aytha","family":"Swathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2024.111409_bib1","unstructured":"Administration, D.E., 2021. 2020 National Drug Threat Assessment.\u00a0\u3008https:\/\/www.dea.gov\/sites\/default\/files\/2021-02\/DIR-008-21%202020%20National%20Drug%20Threat%20Assessment_WEB.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib2","unstructured":", Substance Abuse and Mental Health Services Administration. National Mental Health Services Survey (N-MHSS): 2019. Data on Mental Health Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2020. .."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib3","unstructured":", Substance Abuse and Mental Health Services Administration, National Mental Health Services Survey (N-MHSS): 2020. Data on Mental Health Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2021. ."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib4","unstructured":", Substance Abuse and Treatment Services Administration. 2022. Treatment Episode Data Set (TEDS). Substance Abuse and Mental Health Services Administration. Accessed June 17, 2022.\u00a0\u3008https:\/\/www.samhsa.gov\/data\/data-we-collect\/teds-treatment-episode-data-set\u3009.."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib5","unstructured":", Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health (NSDUH), 2023.Accessed January 16, 2023.\u00a0.."},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.111409_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11011-014-9496-5","article-title":"Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors","volume":"29","author":"Akindipe","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib7","first-page":"858","article-title":"Clinical and economic burden of hospitalizations for infective endocarditis in the United States","author":"Alkhouli","year":"2020","journal-title":"Elsevier"},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.111409_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/002204260703700303","article-title":"Retirement, social support, and drinking behavior: a cohort analysis of males with a baseline history of problem drinking","volume":"37","author":"Bacharach","year":"2007","journal-title":"J. Drug Issues"},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.111409_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10550490490512834","article-title":"Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia","volume":"13","author":"Batki","year":"2004","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.111409_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/16066350500270901","article-title":"Life with jib: a snapshot of street youth's use of crystal methamphetamine","volume":"14","author":"Bungay","year":"2006","journal-title":"Addict. Res. Theory"},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.111409_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08897077.2012.726959","article-title":"National trends in psychostimulant-related deaths: 1999-2009","volume":"34","author":"Calcaterra","year":"2013","journal-title":"Subst. Abus."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.111409_bib12","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1038\/s41467-022-33686-y","article-title":"Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017-2021","volume":"13","author":"Cassell","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib13","unstructured":"CfMMS (CMS), 2023b. Chronic Conditions Data Warehouse Updated 2023. Accessed January 16, 2023.\u00a0.\u3008https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories-other\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib14","unstructured":"CfMMS\u00a0(CMS), 2023a. About the Chronic Conditions Warehouse. Accessed January 16, 2023.\u00a0.\u3008https:\/\/www2.ccwdata.org\/web\/guest\/about-ccw\u3009."},{"issue":"8","key":"10.1016\/j.drugalcdep.2024.111409_bib15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S0033291703008353","article-title":"Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis","volume":"33","author":"Chen","year":"2003","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.111409_bib16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/acem.12803","article-title":"Associations of mental health and substance use disorders with presenting problems and outcomes in older adults' emergency department visits","volume":"22","author":"Choi","year":"2015","journal-title":"Acad. Emerg. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.111409_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mcna.2021.08.010","article-title":"Understanding stimulant use and use disorders in a new era","volume":"106","author":"Ciccarone","year":"2022","journal-title":"Med Clin. N. Am."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.04.009","article-title":"Nationwide increase in hospitalizations for heroin-related soft tissue infections: associations with structural market conditions","volume":"163","author":"Ciccarone","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"16","key":"10.1016\/j.drugalcdep.2024.111409_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018370","article-title":"Methamphetamine-associated heart failure hospitalizations across the United States: geographic and social disparities","volume":"10","author":"Dickson","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib21","unstructured":"Dupree, L.W., Schonfeld, L., 2005. Substance Abuse Relapse Prevention for Older Adults: A Group Treatment Approach.\u00a0US Department of Health and Human Services, Substance Abuse and Mental."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib22","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2105\/AJPH.2021.306698","article-title":"Far from a \u201cwhite problem\u201d: responding to the overdose crisis as a racial justice issue","author":"Friedman","year":"2022","journal-title":"Am. Public Health Assoc."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021","author":"Friedman","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102079","article-title":"Evolving trends in drug overdose mortality in the USA from 2000 to 2020: an age-period-cohort analysis","volume":"61","author":"Fujita-Imazu","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"12","key":"10.1016\/j.drugalcdep.2024.111409_bib26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40263-014-0209-8","article-title":"Methamphetamine psychosis: epidemiology and management","volume":"28","author":"Glasner-Edwards","year":"2014","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.111409_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10550490701861110","article-title":"Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up","volume":"17","author":"Glasner-Edwards","year":"2008","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.111409_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/10550490701756070","article-title":"Risk factors for suicide attempts in methamphetamine-dependent patients","volume":"17","author":"Glasner-Edwards","year":"2008","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.drugalcdep.2024.111409_bib30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.111409_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/jamapsychiatry.2020.4321","article-title":"Methamphetamine overdose deaths in the US by sex and race and ethnicity","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib32","unstructured":"Health CfMaMSOoM, 2023. CMS Framework for Health Equity 2022\u20132032.\u00a0\u3008https:\/\/www.cms.gov\/files\/document\/cms-framework-health-equity-2022.pdf\u3009."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.111409_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/JAN.0000000000000058","article-title":"A review of treatment options for co-occurring methamphetamine use disorders and depression","volume":"26","author":"Hellem","year":"2015","journal-title":"J. Addict. Nurs."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103791","article-title":"The practice and embodiment of \u201cgoofballs\u201d: a qualitative study exploring the co-injection of methamphetamines and opioids","volume":"107","author":"Ivsins","year":"2022","journal-title":"Int. J. Drug Policy"},{"issue":"12","key":"10.1016\/j.drugalcdep.2024.111409_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","article-title":"Patterns and characteristics of methamphetamine use among adults\u2014United States, 2015\u20132018","volume":"69","author":"Jones","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib36","article-title":"Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction","author":"Jones","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2105\/AJPH.2019.305527","article-title":"Resurgent methamphetamine use at treatment admission in the United States, 2008-2017","volume":"110","author":"Jones","year":"2020","journal-title":"Am. J. Public Health"},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.111409_bib39","first-page":"635","article-title":"Risk factors for methamphetamine-induced paranoia and latency of symptom onset in a Thai drug treatment cohort","volume":"3","author":"Kalayasiri","year":"2009","journal-title":"Asian Biomed."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.111409_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.111409_bib41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cger.2014.04.008","article-title":"Substance abuse among older adults","volume":"30","author":"Kuerbis","year":"2014","journal-title":"Clin. Geriatr. Med."},{"issue":"9","key":"10.1016\/j.drugalcdep.2024.111409_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.111409_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1521-0391.2009.00014.x","article-title":"Methamphetamine and paranoia: the methamphetamine experience questionnaire","volume":"19","author":"Leamon","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.psychres.2018.05.033","article-title":"The prevalence of substance-induced psychotic disorder in methamphetamine misusers: a meta-analysis","volume":"268","author":"Lecomte","year":"2018","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.drugalcdep.2024.111409_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.9471","article-title":"Types of hospitals in the United States","volume":"320","author":"Liu","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.111409_bib46","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1360-0443.2010.02932.x","article-title":"Health outcomes associated with methamphetamine use among young people: a systematic review","volume":"105","author":"Marshall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib47","unstructured":"Mattson, M.E., 2014. Emergency Department Visits Involving Methamphetamine: 2007 to 2011. The CBHSQ Report."},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.111409_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1465-3362.2009.00160.x","article-title":"The risk of psychotic symptoms associated with recreational methamphetamine use","volume":"29","author":"McKetin","year":"2010","journal-title":"Drug Alcohol Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.111409_bib50","first-page":"S51","article-title":"Major depression among methamphetamine users entering drug treatment programs","volume":"195","author":"McKetin","year":"2011","journal-title":"Med. J. Aust."},{"issue":"10","key":"10.1016\/j.drugalcdep.2024.111409_bib51","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","article-title":"The prevalence of psychotic symptoms among methamphetamine users","volume":"101","author":"McKetin","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib52","unstructured":"ML B, 2017. 2015 Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample: Change in Structure and Data Elements Caused by Transition to ICD-10-CM\/PCS. November 13, 2017. Accessed June 17, 2022.\u00a0\u3008https:\/\/hcup-us.ahrq.gov\/db\/nation\/nis\/2015HCUPNationalInpatientSample.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib53","unstructured":"National Cancer Institute DoCCPS, 2023. Surveillance Research Program. Number of Jointpoints. Accessed September 29, 2023.\u00a0\u3008https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/number-of-joinpoints\u3009."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.111409_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-023-00816-8","article-title":"The motives and methods of methamphetamine and 'heroin' co-use in West Virginia","volume":"20","author":"Ondocsin","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108089","article-title":"Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018","volume":"213","author":"Palamar","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib56","unstructured":"Prevention CfDCa, 2022. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). National Center for Health Statistics. Updated October 17, 2022. Accessed January 16, 2023.\u00a0\u3008https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm.htm\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib57","unstructured":"Prevention CfDCa, 2023. Bridged-Race Population Estimates \u2013 Data Files and Documentation. Accessed September 1, 2023.\u00a0\u3008https:\/\/www.cdc.gov\/nchs\/nvss\/bridged_race\/data_documentation.htm\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib58","unstructured":"Quality AfHRa, 2022. Overview of the National (Nationwide) Inpatient Sample (NIS). Agency for Healthcare Research and Quality. June 17, 2022. Accessed June 17, 2022.\u00a0\u3008https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp#about\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib59","unstructured":"Quality AfHRa, 2024. Requirements for Publishing with HCUP Data. Updated January 11, 2023. Accessed April 9, 2024.\u00a0\u3008https:\/\/hcup-us.ahrq.gov\/db\/publishing.jsp\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib60","unstructured":"Quality CfBHSa, 2022. Racial\/ethnic differences in substance use, substance use disorders, and substance use treatment utilization among people aged 12 or older (2015-2019)2021. Publication No PEP21-07-01-001. Accessed August 1, 2022.\u00a0\u3008https:\/\/www.samhsa.gov\/data\/report\/racialethnic-differences-substance-use\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib61","unstructured":"Quinones, S., 2021. \u2018I Don\u2019t Know That I Would Even Call It Meth Anymore\u2019. The Atlantic. online."},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.111409_bib62","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108537","article-title":"Using ICD-10-CM codes to detect illicit substance use: a comparison with retrospective self-report","volume":"221","author":"Rowe","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108087","article-title":"Substance use improvement depends on race\/ethnicity: outpatient treatment disparities observed in a large US national sample","volume":"213","author":"Sahker","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2024.111409_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.psychres.2010.09.014","article-title":"Psychiatric comorbidity in methamphetamine dependence","volume":"186","author":"Salo","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109551","article-title":"Prevalence of mental disorders among people with opioid use disorder: a systematic review and meta-analysis","volume":"238","author":"Santo","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015-2018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108369","article-title":"Characterizing trends in methamphetamine-related health care use when there is no ICD code for \u201cmethamphetamine use disorder","volume":"127","author":"Shearer","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib69","article-title":"Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016\u20132019","volume":"10","author":"Shearer","year":"2024","journal-title":"Drug Alcohol Depend. Rep."},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.111409_bib70","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1080\/10826084.2021.1949612","article-title":"It's crazy what meth can help you do\": lay beliefs, practices, and experiences of using methamphetamine to self-treat symptoms of opioid withdrawal","volume":"56","author":"Silverstein","year":"2021","journal-title":"Subst. Use Misuse"},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.111409_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3056","article-title":"Association between state Medicaid eligibility thresholds and deaths due to substance use disorders","volume":"2","author":"Snider","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2024.111409_bib72","unstructured":"Statistics NCfH, 2019. Census Bureau: Four Geographic Regions and Nine Divisions of the United States."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib73","unstructured":"STROBE, 2023. Statement: Guidelines for Reporting Observational Studies. Updated August 2, 2022. Accessed January 16, 2023.\u00a0\u3008https:\/\/www.equator-network.org\/wp-content\/uploads\/2015\/10\/STROBE_checklist_v4_cross-sectional.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib74","unstructured":"Suh, E., 2019. What is Medicaid and Am I Eligible for it?\u00a0\u3008https:\/\/www.policygenius.com\/health-insurance\/medicaid\/#what-is-medicaid\u3009."},{"key":"10.1016\/j.drugalcdep.2024.111409_bib75","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.comppsych.2013.01.003","article-title":"The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia","volume":"55","author":"Sulaiman","year":"2014","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.111409_bib76","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3758","article-title":"Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.111409_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"Am. J. Addict."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871624003326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871624003326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:12:10Z","timestamp":1723551130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871624003326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":77,"alternative-id":["S0376871624003326"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111409","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015\u20132019","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.111409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111409"}}